EP Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$741K Sell
3,498
-36
-1% -$7.07K ﹤0.01% 861
2026
Q1
$693K Buy
3,534
+61
+2% +$11.9K ﹤0.01% 769
2025
Q4
$603K Buy
+3,473
New +$632K ﹤0.01% 793
2025
Q2
$409K Sell
2,275
-8
-0.4% -$1.39K ﹤0.01% 866
2025
Q1
$386K Sell
2,283
-415
-15% -$68.2K ﹤0.01% 802
2024
Q4
$407K Sell
2,698
-1,273
-32% -$198K ﹤0.01% 759
2024
Q3
$616K Buy
3,971
+1,204
+44% +$180K 0.01% 629
2024
Q2
$379K Sell
2,767
-92
-3% -$12.6K ﹤0.01% 597
2024
Q1
$381K Sell
2,859
-95
-3% -$12.3K ﹤0.01% 573
2023
Q4
$407K Sell
2,954
-533
-15% -$70.1K 0.01% 537
2023
Q3
$425K Sell
3,487
-713
-17% -$95K 0.01% 485
2023
Q2
$538K Buy
+4,200
New +$579K 0.01% 452
2023
Q1
Sell
-5,436
Closed -$850K 653
2022
Q4
$850K Buy
+5,436
New +$781K 0.02% 307
2022
Q3
Sell
-7,727
Closed -$1.03M 405
2022
Q2
$1.03M Sell
7,727
-383
-5% -$52.2K 0.02% 254
2022
Q1
$1.11M Sell
8,110
-10
-0.1% -$1.39K 0.02% 259
2021
Q4
$1.41M Sell
8,120
-392
-5% -$59.6K 0.03% 220
2021
Q3
$1.24M Sell
8,512
-6,322
-43% -$925K 0.03% 216
2021
Q2
$1.96M Sell
14,834
-3,970
-21% -$520K 0.05% 180
2021
Q1
$2.41M Buy
+18,804
New +$2.32M 0.08% 151

Other funds holding DGX

EP Wealth Advisors's DGX Position: Q2 2026 in Review

EP Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 1% in Q2 2026, selling an estimated $7.07K and leaving 3,498 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

EP Wealth Advisors first reported a position in DGX in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.41M in Q1 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • EP Wealth Advisors held 3,498 shares of Quest Diagnostics worth $741K as of Q2 2026.
  • EP Wealth Advisors sold 36 Quest Diagnostics shares in Q2 2026, an estimated $7.07K.
  • Quest Diagnostics made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #861 holding.
  • EP Wealth Advisors first reported a position in Quest Diagnostics in Q1 2021 and has held it in 19 quarters since.
  • EP Wealth Advisors's Quest Diagnostics position peaked at $2.41M in Q1 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.